These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 712726)

  • 1. Hormonal status in normal, osteoporotic and corticosteroid-treated postmenopausal women.
    Crilly R; Cawood M; Marshall DH; Nordin BE
    J R Soc Med; 1978 Oct; 71(10):733-6. PubMed ID: 712726
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma androstenedione and oestrone levels in normal and osteoporotic postmenopausal women.
    Marshall DH; Crilly RG; Nordin BE
    Br Med J; 1977 Nov; 2(6096):1177-9. PubMed ID: 589072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relation between plasma androstenedione and oestrone levels in untreated and corticosteroid-treated post-menopausal women.
    Marshall DH; Crilly R; Nordin BE
    Clin Endocrinol (Oxf); 1978 Nov; 9(5):407-12. PubMed ID: 719911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentration of cytosolic estrogen receptors in patients with postmenopausal osteoporosis.
    Davidson BJ; Riggs BL; Coulam CB; Toft DO
    Am J Obstet Gynecol; 1980 Feb; 136(4):430-3. PubMed ID: 7355923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic effects of corticosteroid therapy in post-menopausal women.
    Crilly RG; Marshall DH; Nordin BE
    J Steroid Biochem; 1979 Jul; 11(1B):429-33. PubMed ID: 158677
    [No Abstract]   [Full Text] [Related]  

  • 6. Lack of hormonal changes in postmenopausal women of equal weight with and without osteoporosis, including relation to time of menopause.
    Rico H; Charro A; Depablos I; Bordiu E; Hernandez ER; Espinos D
    Clin Rheumatol; 1984 Sep; 3(3):337-43. PubMed ID: 6488712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, pathogenesis and treatment of post-menopausal osteoporosis.
    Crilly R; Horsman A; Marshall DH; Nordin BE
    Aust N Z J Med; 1979 Feb; 9(1):24-30. PubMed ID: 313208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of serum concentrations of sex steroids and bone turnover in the development and occurrence of postmenopausal osteoporosis.
    Riis BJ; Rødbro P; Christiansen C
    Calcif Tissue Int; 1986 Jun; 38(6):318-22. PubMed ID: 3089552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability and interrelations among serum sex hormones in postmenopausal women.
    Cauley JA; Gutai JP; Kuller LH; Powell JG
    Am J Epidemiol; 1991 Jan; 133(1):50-7. PubMed ID: 1983898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium metabolism and osteoporosis in corticosteroid-treated postmenopausal women.
    Need AG; Philcox JC; Hartley TF; Nordin BE
    Aust N Z J Med; 1986 Jun; 16(3):341-6. PubMed ID: 3465310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behaviour of some steroids in postmenopausal women with coelomic ovarian tumors.
    Pelusi G; Moretti B; Cavallina R; Busacchi P; Martinelli G
    Eur J Gynaecol Oncol; 1983; 4(3):224-8. PubMed ID: 6313369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical characteristics and sex hormone levels in patients with osteoporotic hip fractures or endometrial cancer.
    Laufer LR; Davidson BJ; Ross RK; Lagasse LD; Siiteri PK; Judd HL
    Am J Obstet Gynecol; 1983 Mar; 145(5):585-90. PubMed ID: 6681938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hormonal activity of the postmenopausal ovary.
    Vermeulen A
    J Clin Endocrinol Metab; 1976 Feb; 42(2):247-53. PubMed ID: 177438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of calcium supplementation on urinary hydroxyproline in osteoporotic postmenopausal women.
    Horowitz M; Need AG; Philcox JC; Nordin BE
    Am J Clin Nutr; 1984 Jun; 39(6):857-9. PubMed ID: 6720619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of diurnal variation in plasma levels of androstenedione, testosterone, estrone and estradiol in postmenopausal women.
    Lønning PE; Dowsett M; Jacobs S; Schem B; Hardy J; Powles TJ
    J Steroid Biochem; 1989; 34(1-6):551-3. PubMed ID: 2626050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone mineral density in Addison's disease: evidence for an effect of adrenal androgens on bone mass.
    Devogelaer JP; Crabbé J; Nagant de Deuxchaisnes C
    Br Med J (Clin Res Ed); 1987 Mar; 294(6575):798-800. PubMed ID: 2952217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depo-medroxyprogesterone acetate compared with conjugated estrogens for the treatment of postmenopausal women.
    Lobo RA; McCormick W; Singer F; Roy S
    Obstet Gynecol; 1984 Jan; 63(1):1-5. PubMed ID: 6318170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androstenedione metabolism in patients with endometrial cancer.
    Calanog A; Sall S; Gordon GG; Southren AL
    Am J Obstet Gynecol; 1977 Nov; 129(5):553-6. PubMed ID: 910844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian and adrenal contributions to peripheral steroid levels in postmenopausal women.
    Maroulis GB; Abraham GE
    Obstet Gynecol; 1976 Aug; 48(2):150-4. PubMed ID: 133306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen-estrogen production rates in postmenopausal women with breast cancer.
    Kirschner MA; Cohen FB; Ryan C
    Cancer Res; 1978 Nov; 38(11 Pt 2):4029-35. PubMed ID: 568029
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.